Page 31 - 中国全科医学2022-08
P. 31

·924· http://www.chinagp.net   E-mail:zgqkyx@chinagp.net.cn


                                                                                                 ·论著·


           高迁移率族蛋白 B1 联合急性生理学评分

           对重症肺炎患儿诊断价值及预后价值的研究

                                                                                             扫描二维码
                      *
           康平,李奕 ,汤昱                                                                          查看原文

               【摘要】 背景 小儿重症肺炎是临床常见的呼吸系统危重症,准确评估其预后是合理临床决策的关键。高迁移
           率族蛋白 B1(HMGB1)水平及急性生理学评分(APS)对成人危重症预后意义较高,但对重症肺炎患儿的诊断及预
           后价值尚不明确。目的 探讨 HMGB1 水平联合 APS 在重症肺炎患儿诊断及预后中的价值。方法 选取 2020年 5月
           至 2021 年 2 月在郑州大学附属儿童医院治疗的 55 例重症肺炎患儿(重症肺炎组),根据预后情况将患儿分为转归亚
           组(n=41)和预后不良亚组(n=14);选取同期在本院治疗的普通肺炎患儿 60 例(普通肺炎组)及健康体检儿童 40
           例(对照组)。比较各组儿童入院时 HMGB1 水平及 APS,分析 HMGB1 水平与 APS 相关性,采用多因素 Logistic 回归
           分析探讨影响重症肺炎预后的因素,采用受试者工作特征(ROC)曲线分析 HMGB1 水平、APS 及两者联合对重症肺
           炎患儿诊断及预后的价值。结果 重症肺炎组 HMGB1 水平、APS 高于普通肺炎组(P<0.05);预后不良亚组 HMGB1
           水平、APS 高于转归亚组(P<0.05)。Pearson 相关分析显示,重症肺炎组 HMGB1 水平与 APS 呈正相关(r=0.542,
           P<0.001)。多因素 Logistic 回归分析显示,HMGB1 水平〔OR=8.411,95%CI(1.411,50.137),P<0.05〕、APS〔OR=5.724,
           95%CI(1.108,29.572),P<0.05〕是重症肺炎患儿预后不良的影响因素。HMGB1 水平及 APS 联合诊断重症肺炎
           患儿的 ROC 曲线下面积为 0.975〔95%CI(0.918,0.996)〕,最佳截断值为 -0.203,灵敏度为 98.18%,特异度为
           96.67%;HMGB1 水平及 APS 联合诊断重症肺炎患儿预后的 ROC 曲线下面积为 0.923〔95%CI(0.819,0.978)〕,最
           佳截断值为 -0.030,灵敏度为 97.56%,特异度为 92.86%。结论 HMGB1 水平和 APS 均是重症肺炎患儿预后不良的影
           响因素,两者联合可进一步提高对重症肺炎患儿预后的诊断能力。
               【关键词】 重症肺炎;儿童;高迁移率族蛋白 B1;急性生理学评分;预后;灵敏度;特异度;影响因素分析;
           诊断;预测价值
               【中图分类号】 R 563.1 【文献标识码】 A DOI:10.12114/j.issn.1007-9572.2021.01.410
               康平,李奕,汤昱 . 高迁移率族蛋白 B1 联合急性生理学评分对重症肺炎患儿诊断价值及预后价值的研究[J].
           中国全科医学,2022,25(8):924-929,936.[www.chinagp.net]
               KANG P,LI Y,TANG Y. The study of the value of high mobility group protein B1 combined with acute physiological score in
           the diagnosis and prognosis of children with severe pneumonia[J]. Chinese General Practice,2022,25(8):924-929,936.


           The Study of the Value of High Mobility Group Protein B1 Combined with Acute Physiological Score in the Diagnosis
                                                                 *
           and Prognosis of Children with Severe Pneumonia KANG Ping,LI Yi ,TANG Yu
           Respiratory Department,Children's Hospital Affiliated to Zhengzhou University,Zhengzhou 450000,China
           *
           Corresponding author:LI Yi,Pharmacist-in-charge;E-mail:lkyypl@163.com
               【Abstract】 Background Severe pneumonia in children is a common respiratory critical illness,and accurate
           assessment of its prognosis is the key to reasonable clinical decision-making. High mobility group protein B1(HMGB1)and
           acute physiology score(APS)have high prognostic significance for adult critically ill patients,but the value of diagnosis and
           prognosis in children with severe pneumonia is still unclear. Objective To investigate the value of HMGB1 combined with APS
           in the diagnosis and prognosis of children with severe pneumonia. Methods The data of 55 children with severe pneumonia
           (severe pneumonia group)treated in Children's Hospital affiliated to Zhengzhou University from May 2020 to February 2021
           were collected and the childrenwere divided into the improvement subgroup(n=41)and the poor outcome subgroup(n=14)
           according to the prognosis. Data of 60 children with common pneumonia(common pneumonia group)and 40 children with
           healthy physical examination(control group)who were treated in this hospital during the same period. The APS score and
           HMGB1 level at admission of each groupwere compared. The correlation between APS and HMGB1 was analyzed. The risk factors

               基金项目:河南省医学科技攻关计划项目(LHGJ20190907)
               450000 河南省郑州市,郑州大学附属儿童医院呼吸科
               *
               通信作者:李奕,主管药师;E-mail:lkyypl@163.com
               本文数字出版日期:2022-01-27
   26   27   28   29   30   31   32   33   34   35   36